Copyright
©The Author(s) 2005.
World J Gastroenterol. Aug 14, 2005; 11(30): 4721-4726
Published online Aug 14, 2005. doi: 10.3748/wjg.v11.i30.4721
Published online Aug 14, 2005. doi: 10.3748/wjg.v11.i30.4721
Omeprazole (n = 14) | ||
Endoscopy (mo) | 0 | 6 |
Proliferation index (%) | 40.9 ± 13.8 | 54.1 ± 16.6 |
Apoptosis (%) | 45.3 ± 8.7 | 49.5 ± 10.3 |
P53 (%) | 28.7 ± 4.3 | 28.9 ± 12.7 |
EGFR (%) | 17.6 ± 11.9 | 21.9 ± 7.9 |
Esomeprazole (n = 12) | ||
Endoscopy (mo) | 0 | 6 |
Proliferation index (%) | 39.6 ± 8.7 | 52.8 ± 10.4 |
Apoptosis (%) | 43.5 ± 9.8 | 48.9 ± 9.8 |
P53 (%) | 29.2 ± 10.7 | 29.6 ± 11.5 |
EGFR (%) | 16.8 ± 8.1 | 22.3 ± 8.1 |
- Citation: Hritz I, Herszenyi L, Molnar B, Tulassay Z, Pronai L. Long-term omeprazole and esomeprazole treatment does not significantly increase gastric epithelial cell proliferation and epithelial growth factor receptor expression and has no effect on apoptosis and p53 expression. World J Gastroenterol 2005; 11(30): 4721-4726
- URL: https://www.wjgnet.com/1007-9327/full/v11/i30/4721.htm
- DOI: https://dx.doi.org/10.3748/wjg.v11.i30.4721